You are viewing an incomplete version of our website. Please click to reload the website as full version.

CEBPA antibody (CCAAT/enhancer Binding Protein (C/EBP), alpha) (AA 304-330)

Details for Product anti-CEBPA Antibody No. ABIN653431, Supplier: Log in to see
Antigen
  • C/EBP
  • C/EBP-alpha
  • c/ebpa
  • C/EBPalpha
  • C/EBP alpha
  • C/ebpalpha
  • cb1062
  • CBF-A
  • cC/EBP
  • Cebp
  • CEBP
  • DBPCEP
  • wu:fj20f03
  • xC/EBP
Epitope
AA 304-330, C-Term
22
22
13
13
9
9
7
6
4
3
3
3
2
2
1
1
1
1
1
1
1
1
1
1
Reactivity
Human, Mouse (Murine)
135
72
67
4
3
3
3
2
1
1
1
Host
Rabbit
118
20
3
2
Clonality (Clone)
Polyclonal ()
Conjugate
This CEBPA antibody is un-conjugated
3
3
3
2
2
2
1
1
1
1
1
1
1
1
1
Application
Flow Cytometry (FACS), Western Blotting (WB)
118
62
33
28
16
13
8
7
3
3
2
1
1
Supplier
Log in to see
Supplier Product No.
Log in to see
Request

Get this product for free

It's quick and easy to submit your validation proposal. I want to validate this product

Learn more

Available images

Immunogen This CEBPA antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 304-330 AA from the C-terminal region of human CEBPA.
Clone RB23215
Isotype Ig
Specificity This CEBPA antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 310~339 amino acids from the C-terminal region of human CEBPA.
Predicted Reactivity Cow (Bovine),Rat (Rattus)
Purification This antibody is purified through a protein A column, followed by peptide affinity purification.
Alternative Name CEBPA (CEBPA Antibody Abstract)
Background CEBPA is a bZIP transcription factor which can bind as a homodimer to certain promoters and enhancers. It can also form heterodimers with the related proteins CEBP-beta and CEBP-gamma. This protein has been shown to bind to the promoter and modulate the expression of the gene encoding leptin, a protein that plays an important role in body weight homeostasis. Also, the protein can interact with CDK2 and CDK4, thereby inhibiting these kinases and causing growth arrest in cultured cells.
Synonyms: CCAAT/enhancer-binding protein alpha, C/EBP alpha, CEBPA
Molecular Weight 37561 DA
Gene ID 1050
UniProt P49715
Research Area Signaling, Protein Modifications, Transcription Factors
Application Notes WB = 1:1000, FACS = 1:10-50
Restrictions For Research Use only
Format Liquid
Concentration 0.5 mg/mL
Buffer PBS with 0.09 % (W/V) sodium azide
Preservative Sodium azide
Precaution of Use This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage 4 °C/-20 °C
Storage Comment Maintain refrigerated at 2-8 °C for up to 6 months. For long term storage store at -20 °C in small aliquots to prevent freeze-thaw cycles.
Expiry Date 6 months
Supplier Images
Western Blotting (WB) image for anti-CEBPA antibody (CCAAT/enhancer Binding Protein (C/EBP), alpha) (AA 304-330) (ABIN653431) Western blot analysis of CEBPA Antibody (C-term) (ABIN653431) in mouse liver tissue l...
Background publications Nanri, Uike, Kawakita, Iwanaga, Mitsuya, Asou: "A family harboring a germ-line N-terminal C/EBPalpha mutation and development of acute myeloid leukemia with an additional somatic C-terminal C/EBPalpha mutation." in: Genes, chromosomes & cancer, Vol. 49, Issue 3, pp. 237-41, 2010

Burnett, Hills, Green, Jenkinson, Koo, Patel, Guy, Gilkes, Milligan, Goldstone, Prentice, Wheatley, Linch, Gale: "The impact on outcome of the addition of all-trans retinoic acid to intensive chemotherapy in younger patients with nonacute promyelocytic acute myeloid leukemia: overall results and results in genotypic subgroups defined by mutations in NPM1, FLT3, and C" in: Blood, Vol. 115, Issue 5, pp. 948-56, 2010

Dufour, Schneider, Metzeler, Hoster, Schneider, Zellmeier, Benthaus, Sauerland, Berdel, Büchner, Wörmann, Braess, Hiddemann, Bohlander, Spiekermann: "Acute myeloid leukemia with biallelic CEBPA gene mutations and normal karyotype represents a distinct genetic entity associated with a favorable clinical outcome." in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 28, Issue 4, pp. 570-7, 2010